China Digest: MingMed raises $50m; Hongtai Aplus backs RCD

MingMed Biotechnology, a startup that develops pharmaceutical products, has completed raising nearly $50 million in its Series A+ round. In a separate development, RCD, that operates charging stations for smart cars, has garnered approximately 100 million yuan ($15 million) in its Series B+ round led by Hongtai Aplus.